CD28 and melanoma: In their experiments, Verdhana et al. re-stimulated mouse T cells that had been pre-activated for 48 h with anti-CD3/CD28-coated plates, with either an OVA-expressing B16–F10 melanoma cell line or anti-CD3-coated plates for an additional 8 days [110].